Katharina Hopp

6PUBLICATIONS
12CO-AUTHORS
Molecular targetsCancer geneticsMedical infection agents (incl. prions)PharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 12, 2025
Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease.

Christopher Y Chen, Mohamad Hadla, Ibrahim Khambati

|Jan 17, 2022
Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.

Katharina Hopp, Emily K Kleczko, Berenice Y Gitomer

|Dec 06, 2021
15-Lipoxygenase worsens renal fibrosis, inflammation, and metabolism in a murine model of ureteral obstruction.

John R Montford, Colin Bauer, Jeremy Rahkola

|Aug 21, 2019
Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.

Rory J Olson, Katharina Hopp, Harrison Wells

|Aug 12, 2018
Characterization of three ciliopathy pedigrees expands the phenotype associated with biallelic C2CD3 variants.

Nicole J Boczek, Katharina Hopp, Lacey Benoit

Pageof 1